胜肽合成市場：按產品、技術、應用、最終用戶和地區分類

預計到 2026 年，胜肽合成市場規模將達到 5.595 億美元，到 2033 年將達到 9.465 億美元。預計從 2026 年到 2033 年，該市場將以 7.8% 的複合年成長率成長，達到 9.465 億美元。

肽是由胺基酸單體透過肽鍵（醯胺鍵）連接而成的短鏈。其長度範圍為2至50個氨基酸。胜肽主要分為兩大類：“線性胜肽”，其中胺基酸首尾相連形成鎖狀結構；以及“環狀胜肽”，其中氨基和羧端透過胜肽鍵連接形成環狀結構。胜肽在生物學和醫藥領域發揮著多種重要的作用。

胜肽的合成主要有兩種方法：固相合成和液相合成。固相胜肽合成是最常用的方法，因為它比液相合成更容易純化，且產率更高。在固相合成中，首先將胺基酸鍵結到不溶性聚合物載體上。然後，逐步添加胺基酸來延長肽鏈。最後，可以透過將胜肽從樹脂載體上切割下來輕鬆純化。環肽的合成更具挑戰性，需要天然化學連接和環化複分解等技術。固相合成可以實現大規模生產，但需要昂貴的設備和特殊的材料。液相合成較簡單，但產率較低，且產生的胜肽含有雜質，需要分離。

市場動態

肽合成已成為生物有機化學領域最重要的調查方法之一，廣泛應用於研究和診斷。此外，瘧疾等感染疾病的發生率預計將推動市場成長。例如，截至2025年8月21日，美國疾病管制與預防中心（CDC）指出，美國瘧疾風險極低。瘧疾不像普通感冒或流感那樣人傳人，也不是性行為感染傳染病。美國每年報告的瘧疾病例約2000例。其中大多數病例發生在曾前往瘧疾流行地區的旅客身上。

此外，根據美國國家生物技術資訊中心（NCBI）2025年2月10日發布的報告，全球每年約有2億例瘧疾病例，造成近50萬人死亡。超過90%的瘧疾死亡病例發生在撒哈拉以南非洲地區。五歲以下兒童尤其容易感染瘧疾。大約每兩分鐘就有一名兒童死於瘧疾。

本研究的關鍵特徵

• 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
• 本研究根據以下參數對全球胜肽合成市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
• 透過利用本報告中的見解，企業行銷負責人和經營團隊可以就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 全球肽合成市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過分析全球肽合成市場中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• 一致性機會圖（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 來自製藥業的需求不斷成長
  • 對設備和技術的大量資本投資
  • 拓展胜肽在藥用化妝品和營養保健品中的應用。
• 影響分析
• 監管趨勢
• 服務提供組合
• PEST分析
• 波特的分析
• 併購情景

第4章 全球胜肽合成市場：依產品分類，2021-2033年

• 試劑和耗材
• 裝置

第5章 全球胜肽合成市場：依技術分類，2021-2033年

• 固相
• 液相
• 雜交和重組

第6章 全球胜肽合成市場：依應用領域分類，2021-2033年

• 治療
• 診斷
• 研究

第7章 全球胜肽合成市場：依最終用戶分類，2021-2033年

• 生物製藥公司
• 合約開發與生產組織（CDMO）/受託研究機構（CRO）
• 研究機構
• 其他

第8章 全球胜肽合成市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 中東
  • GCC
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第9章 競爭情勢

• GenScript BIoTech Corporation
• Merck KGaA
• ThermoFisher Scientific Inc.
• Syngene
• Lonza
• Novo Nordisk A/S
• Bachem Holding AG
• Gyros Protein Technologies
• Creative Diagnostics
• CEM Corporation
• PuroSynth
• AAPPTec
• BIoTage AB
• AnaSpec
• ABclonal, Inc.
• Novelgene Technologies

第10章

• 調查方法
• 關於本公司

Peptide Synthesis Market is estimated to be valued at USD 559.5 Mn in 2026 and is expected to reach USD 946.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.8%USD 946.5 Mn from 2026 to 2033.

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds. They can range from 2 to 50 amino acids in length. There are two main types of peptides linear peptides, which contain amino acids linked end-to-end in a chain, and cyclic peptides, which form a ring structure with their amino and carboxyl termini connected via a peptide bond. Peptides serve various important biological functions and pharmaceutical applications.

There are mainly solid-phase and liquid-phase peptide synthesis methods. Solid-phase peptide synthesis is the most commonly used method, as it allows easy purification and produces higher yields compared to liquid-phase synthesis. In the solid phase, the first amino acid is attached to an insoluble polymer support. Subsequent amino acids are then added step-by-step to grow the peptide chain. The peptide is then cleaved off the resin support and can be easily purified. Cyclic peptides pose additional challenges for synthesis and require methods like native chemical ligation or ring-closing metathesis. While solid-phase synthesis enables mass production, it requires expensive equipment and specialized materials. Liquid-phase synthesis is simpler but produces lower yields and impure peptides requiring separation.

Market Dynamics

Peptide synthesis has become one of the most important methodologies in bio-organic chemistry for research and diagnosis. Moreover, the incidence of infectious diseases such as malaria and others is expected to boost market growth. For instance, on August 21, 2025, according to the Centers for Disease Control and Prevention, the risk of malaria in the U.S. is very low. People do not spread malaria to other people, like the common cold or the flu. Also, malaria is not sexually transmitted. The U.S. reports about 2,000 cases of malaria each year. Most of these cases are in people traveling to areas where malaria spreads.

Furthermore, on February 10, 2025, according to the report published by the National Center for Biotechnology Information, every year, there are about 200 million cases of malaria globally, resulting in almost half a million deaths annually. Over 90% of all malaria deaths occur in sub-Saharan Africa. Children under the age of 5 are disproportionately affected by malaria. A child dies of malaria approximately every 2 minutes.

Key features of the study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global peptide synthesis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative Diagnostics, CEM Corporation, PuroSynth, AAPPTec, Biotage AB, AnaSpec, ABclonal, Inc. and Novelgene Technologies.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global peptide synthesis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peptide synthesis market.

Market Segmentation

• By Product (Revenue, USD Mn, 2021 - 2033)
• Reagents & Consumables
• Equipment
  • Peptide Synthesizers
  • Lyophilizer
  • Chromatography Equipment
• By Technology (Revenue, USD Mn, 2021 - 2033)
• Solid Phase
• Liquid Phase
• Hybrid and Recombinant
• By Application (Revenue, USD Mn, 2021 - 2033)
• Therapeutics
  • Metabolic Disorders
  • Cardiovascular Disorders
  • Respiratory Disorders
  • Infectious Diseases
  • Others
• Diagnosis
• Research
• By End User (Revenue, USD Mn, 2021 - 2033)
• Biopharmaceutical Companies
• Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
• Research Institutes
• Others
• By Region (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Top companies in Global Peptide Synthesis Market
• GenScript Biotech Corporation
• Merck KGaA
• ThermoFisher Scientific Inc.
• Syngene
• Lonza
• Novo Nordisk A/S
• Bachem Holding AG
• Gyros Protein Technologies
• Creative Diagnostics
• CEM Corporation
• PuroSynth
• AAPPTec
• Biotage AB
• AnaSpec
• ABclonal, Inc.
• Novelgene Technologies

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Peptide Synthesis Market, By Product
  • Global Peptide Synthesis Market, By Technology
  • Global Peptide Synthesis Market, By Application
  • Global Peptide Synthesis Market, By End User
  • Global Peptide Synthesis Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Growing Demand from Pharmaceutical Industry
  • High capital investment for equipment and technology
  • Growing applications of peptides in cosmeceuticals and nutraceuticals
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Service offering Portfolio
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Peptide Synthesis Market, By Product, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Reagents & Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Equipment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Peptide Synthesizers
    • Lyophilizer
    • Chromatography Equipment

5. Global Peptide Synthesis Market, By Technology, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Solid Phase
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Liquid Phase
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Hybrid and Recombinant
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

6. Global Peptide Synthesis Market, By Application, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Therapeutics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Metabolic Disorders
    • Cardiovascular Disorders
    • Respiratory Disorders
    • Infectious Diseases
    • Others
• Diagnosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

7. Global Peptide Synthesis Market, By End User, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Biopharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

8. Global Peptide Synthesis Market, By Region, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, By Country, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country 2021 - 2033
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• GenScript Biotech Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Merck KGaA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• ThermoFisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Syngene
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Lonza
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Novo Nordisk A/S
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Strategies
• Bachem Holding AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Gyros Protein Technologies
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Creative Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• CEM Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• PuroSynth
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• AAPPTec
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Biotage AB
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• AnaSpec
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• ABclonal, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Novelgene Technologies
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us